{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:01:17Z","timestamp":1783684877439,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05262-z","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:29:58Z","timestamp":1762183798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT)"],"prefix":"10.1007","volume":"176","author":[{"given":"Carlin","family":"Chuck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Amaral-Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Taman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Oldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijal","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasmit","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Elinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cifarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"5262_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuchi.2021.04.001","volume":"68","author":"DK Mitchell","year":"2022","unstructured":"Mitchell DK, Kwon HJ, Kubica PA, Huff WX, O\u2019Regan R, Dey M (2022) Brain metastases: an update on the multi-disciplinary approach of clinical management. Neurochirurgie 68:69\u201385","journal-title":"Neurochirurgie"},{"key":"5262_CR2","first-page":"381","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G et al. (2021) Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin 71:381\u2013406","journal-title":"CA Cancer J Clin"},{"key":"5262_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","volume":"22","author":"BD Fox","year":"2011","unstructured":"Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G (2011) Epidemiology of metastatic brain tumors. Neurosurg Clinics 22:1\u20136","journal-title":"Neurosurg Clinics"},{"key":"5262_CR4","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","volume":"13","author":"NU Lin","year":"2007","unstructured":"Lin NU, Winer EP (2007) Brain Metastases: The HER2 Paradigm. Clin Cancer Res 13:1648\u20131655","journal-title":"Clin Cancer Res"},{"key":"5262_CR5","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 22:2865\u20132872","journal-title":"J Clin Oncol"},{"key":"5262_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA et al. (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 12:265\u2013282","journal-title":"Pract Radiat Oncol"},{"key":"5262_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al. (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. NEJM Evid 352:987\u2013996","journal-title":"NEJM Evid"},{"key":"5262_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clon.2005.08.017","volume":"18","author":"NG Burnet","year":"2006","unstructured":"Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF (2006) Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 18:93\u2013103","journal-title":"Clin Oncol"},{"key":"5262_CR9","first-page":"379","volume":"33","author":"H Park","year":"2025","unstructured":"Park H, Kang D, Lee TH, Oh D (2025) Dynamics in distress and quality of life in patients undergoing radiation therapy: a prospective cohort study. Support Care Cancer 33:379","journal-title":"Support Care Cancer"},{"key":"5262_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijrobp.2018.03.014","volume":"101","author":"JD Palmer","year":"2018","unstructured":"Palmer JD, Patel TT, Eldredge-Hindy H, Keith SW, Patel T, Malatesta T et al. (2018) Patients undergoing radiation therapy are at risk of financial toxicity: a patient-based prospective survey study. Int J Radiat Oncol Biol Phys 101:299\u2013305","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5262_CR11","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2217\/fon-2020-0558","volume":"16","author":"DJ Gessler","year":"2020","unstructured":"Gessler DJ, Ferreira C, Dusenbery K, Chen CC (2020) GammaTile \u00ae: surgically targeted radiation therapy for glioblastomas. Future Oncol 16:2445\u20132455","journal-title":"Future Oncol"},{"key":"5262_CR12","doi-asserted-by":"crossref","unstructured":"Dharnipragada R, Ferreira C, Shah R, Reynolds M, Dusenbery K, Chen CC (2023) GammaTile\u00ae (GT) as a brachytherapy platform for rapidly growing brain metastasis. Neurooncol Adv 5","DOI":"10.1093\/noajnl\/vdad062"},{"key":"5262_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-015-2009-5","volume":"127","author":"A Pham","year":"2016","unstructured":"Pham A, Yondorf MZ, Parashar B, Scheff RJ, Pannullo SC, Ramakrishna R et al. (2016) Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial. J Neurooncol 127:63\u201371","journal-title":"J Neurooncol"},{"key":"5262_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-8140(98)00143-1","volume":"49","author":"JJ Mazeron","year":"1998","unstructured":"Mazeron JJ, Gerbaulet A (1998) The centenary of discovery of radium. Radiother And Oncol 49:205\u2013216","journal-title":"Radiother And Oncol"},{"key":"5262_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0167-8140(98)00137-6","volume":"49","author":"J Dutreix","year":"1998","unstructured":"Dutreix J, Tubiana M, Pierquin B (1998) The hazy dawn of brachytherapy. Radiother And Oncol 49:223\u2013232","journal-title":"Radiother And Oncol"},{"key":"5262_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","volume":"103","author":"M Rapp","year":"2017","unstructured":"Rapp M, Baernreuther J, Turowski B, Steiger HJ, Sabel M, Kamp MA (2017) Recurrence pattern analysis of primary glioblastoma. World Neurosurg 103:733\u2013740","journal-title":"World Neurosurg"},{"key":"5262_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3171\/jns.1987.67.6.0864","volume":"67","author":"PH Gutin","year":"1987","unstructured":"Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL et al. (1987) Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67:864\u2013873","journal-title":"J Neurosurg"},{"key":"5262_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0360-3016(89)90518-X","volume":"17","author":"SA Leibel","year":"1989","unstructured":"Leibel SA, Gutin PH, Wara WM, Silver PS, Larson DA, Edwards MS et al. (1989) Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129\u20131139","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5262_CR19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0360-3016(98)00159-X","volume":"41","author":"NJ Laperriere","year":"1998","unstructured":"Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J et al. (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005\u20131011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5262_CR20","doi-asserted-by":"crossref","unstructured":"Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC et al. The brain tumor cooperative group NIH trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343\u2013355; discussion 355-347. 2002","DOI":"10.1097\/00006123-200208000-00009"},{"key":"5262_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3171\/jns.1992.76.2.0179","volume":"76","author":"RC Florell","year":"1992","unstructured":"Florell RC, Macdonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH et al. (1992) Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76:179\u2013183","journal-title":"J Neurosurg"},{"key":"5262_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-019-03268-y","volume":"145","author":"J Bartek","year":"2019","unstructured":"Bartek J, Alattar AA, Dhawan S, Ma J, Koga T, Nakaji P et al. (2019) Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the surveillance, epidemiology, and end results database. J Neurooncol 145:75\u201383","journal-title":"J Neurooncol"},{"key":"5262_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11060-013-1139-x","volume":"113","author":"JD Waters","year":"2013","unstructured":"Waters JD, Rose B, Gonda DD, Scanderbeg DJ, Russell M, Alksne JF et al. (2013) Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol 113:467\u2013477","journal-title":"J Neurooncol"},{"issue":"8","key":"5262_CR24","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P et al. (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. The Lancet Oncol 18(8):1040\u20131048","journal-title":"The Lancet Oncol"},{"key":"5262_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3171\/jns.2006.105.3.375","volume":"105","author":"LR Rogers","year":"2006","unstructured":"Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL et al. (2006) Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105:375\u2013384","journal-title":"J Neurosurg"},{"key":"5262_CR26","doi-asserted-by":"crossref","unstructured":"Shrieve DC, Alexander E, III Wen PY, Fine HA, Kooy HM et al. (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent Glioblastoma Multiforme. Neurosurgery 36","DOI":"10.1097\/00006123-199502000-00006"},{"key":"5262_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A et al. (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48","journal-title":"Radiat Oncol"},{"issue":"6","key":"5262_CR28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3171\/2020.10.JNS201934","volume":"135","author":"R O\u2019Brien DA","year":"2021","unstructured":"O\u2019Brien DA R, Kaye SM, Poppas PJ, Mahase SS, An A, Christos PJ et al. (2021) Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis. J Neurosurg 135(6):1695\u20131705","journal-title":"J Neurosurg"},{"issue":"2","key":"5262_CR29","first-page":"133","volume":"9","author":"NK Yaghi","year":"2022","unstructured":"Yaghi NK, Radu S, Nugent JG, Mazur-Hart DJ, Pang BW, Bowden SG et al. (2022) Optimal timing of radiotherapy following brain metastases surgery. Neurooncol Pract 9(2):133\u2013141","journal-title":"Neurooncol Pract"},{"issue":"Supplement_2","key":"5262_CR30","first-page":"ii8","volume":"2","author":"DR O\u2019Brien","year":"2020","unstructured":"O\u2019Brien DR, Kaye S, Poppas P, Mahase S, An A, Christos P et al. (2020) 45. Delay or failure to administer stereotactic radiosurgery to the cavity after surgery for brain metastases. An intention-to-treat analysis. Neurooncol Adv 2(Supplement_2):ii8\u2013ii9","journal-title":"Neurooncol Adv"},{"issue":"3","key":"5262_CR31","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.prro.2021.01.011","volume":"11","author":"R O\u2019Brien DA","year":"2021","unstructured":"O\u2019Brien DA R, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ et al. (2021) Timing of adjuvant fractionated stereotactic radiosurgery affects local control of resected brain metastases. Pract Radiat Oncol 11(3):e267\u2013e75","journal-title":"Pract Radiat Oncol"},{"key":"5262_CR32","doi-asserted-by":"crossref","unstructured":"Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C (2020) Optimal timing of radiotherapy following gross total or subtotal resection of Glioblastoma: a real-world assessment using the national cancer database. Sci Rep 10","DOI":"10.1038\/s41598-020-61701-z"},{"key":"5262_CR33","volume-title":"Brachytherapy","author":"C Mayer","year":"2025","unstructured":"Mayer C, Gasalberti DP, Kumar A (2025) Brachytherapy. StatPearls Treasure Island (FL)"},{"key":"5262_CR34","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.radonc.2023.110012","volume":"190","author":"X Xiang","year":"2024","unstructured":"Xiang X, Ji Z, Jin J (2024) Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): a systematic review. Radiother Oncol 190:110012","journal-title":"Radiother Oncol"},{"key":"5262_CR35","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1118\/1.2432162","volume":"34","author":"MJ Rivard","year":"2007","unstructured":"Rivard MJ (2007) Brachytherapy dosimetry parameters calculated for a 131Cs source. Med Phys 34:754\u2013762","journal-title":"Med Phys"},{"key":"5262_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijrobp.2008.05.013","volume":"72","author":"A Sahgal","year":"2008","unstructured":"Sahgal A, Jabbari S, Chen J, Pickett B, Roach M, Weinberg V et al. (2008) Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131Cs and 125I for prostate permanent implant brachytherapy. Int J Multiling Radiat oncol*biol*phys 72:247\u2013254","journal-title":"Int J Multiling Radiat oncol*biol*phys"},{"key":"5262_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.brachy.2024.06.007","volume":"23","author":"T Kutuk","year":"2024","unstructured":"Kutuk T, Kotecha R, Herrera R, Wieczorek DJJ, Fellows ZW, Chaswal V et al. (2024) Surgically targeted radiation therapy versus stereotactic radiation therapy: a dosimetric comparison for brain metastasis resection cavities. Brachytherapy 23:751\u2013760","journal-title":"Brachytherapy"},{"key":"5262_CR38","doi-asserted-by":"crossref","unstructured":"Han DY, Ma L, Braunstein S, Raleigh D, Sneed PK, McDermott M (2018) Resection cavity contraction effects in the Use of radioactive sources (1-25 versus Cs-131) for intra-operative brain implants. Cureus","DOI":"10.7759\/cureus.2079"},{"key":"5262_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3171\/2014.3.JNS131140","volume":"121","author":"AG Wernicke","year":"2014","unstructured":"Wernicke AG, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A et al. (2014) Phase I\/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg 121:338\u2013348","journal-title":"J Neurosurg"},{"key":"5262_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1227\/NEU.0000000000000986","volume":"12","author":"AG Wernicke","year":"2016","unstructured":"Wernicke AG, Lazow SP, Taube S, Yondorf MZ, Kovanlikaya I, Nori D et al. (2016) Surgical technique and clinically relevant resection cavity dynamics following implantation of cesium-131 brachytherapy in patients with brain metastases. Operative Neurosurg 12:49\u201360","journal-title":"Operative Neurosurg"},{"key":"5262_CR41","doi-asserted-by":"publisher","first-page":"vi272","DOI":"10.1093\/neuonc\/nox168.1117","volume":"19","author":"E Youssef","year":"2017","unstructured":"Youssef E, Nakaji P, Thomas T, McBride H, Fram E, Brachman D (2017) SCDT-36. Novel modular, permanently implanted collagen-based device for intraoperative brachytherapy in patients with central nervous system tumors. Neuro-Oncology 19:vi272\u2013vi272","journal-title":"Neuro-Oncology"},{"key":"5262_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11060-023-04523-z","volume":"166","author":"MA Garcia","year":"2024","unstructured":"Garcia MA, Turner A, Brachman DG (2024) The role of GammaTile in the treatment of brain tumors: a technical and clinical overview. J Neurooncol 166:203\u2013212","journal-title":"J Neurooncol"},{"key":"5262_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11060-023-04545-7","volume":"166","author":"A Yekula","year":"2024","unstructured":"Yekula A, Gessler DJ, Ferreira C, Shah R, Reynolds M, Dusenbery K et al. (2024) GammaTile\u00ae (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials. J Neurooncol 166:441\u2013450","journal-title":"J Neurooncol"},{"key":"5262_CR44","doi-asserted-by":"crossref","unstructured":"Gessler DJ, Neil EC, Shah R, Levine J, Shanks J, Wilke C et al. (2022) GammaTile\u00ae brachytherapy in the treatment of recurrent glioblastomas. Neurooncol Adv 4","DOI":"10.1093\/noajnl\/vdab185"},{"key":"5262_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.brachy.2020.06.013","volume":"19","author":"AG Wernicke","year":"2020","unstructured":"Wernicke AG, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH (2020) Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control. Brachytherapy 19:705\u2013712","journal-title":"Brachytherapy"},{"key":"5262_CR46","doi-asserted-by":"crossref","unstructured":"Budnick HC, Richardson AM, Shiue K, Watson G, Ng SK, Le Y et al. (2021) GammaTile for gliomas: a single-Center Case series. Cureus","DOI":"10.7759\/cureus.19390"},{"key":"5262_CR47","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/neuonc\/noac133","volume":"24","author":"K Smith","year":"2022","unstructured":"Smith K, Nakaji P, Thomas T, Pinnaduwage D, Wallstrom G, Choi M et al. (2022) Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: results from a prospective trial. Neuro Oncol 24:S4\u2013s15","journal-title":"Neuro Oncol"},{"key":"5262_CR48","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A et al. (2020) Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma. JAMA Oncol 6:1003","journal-title":"JAMA Oncol"},{"key":"5262_CR49","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1056\/NEJMoa1707358","volume":"377","author":"W Wick","year":"2017","unstructured":"Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I et al. (2017) Lomustine and Bevacizumab in progressive glioblastoma. NEJM Evid 377:1954\u20131963","journal-title":"NEJM Evid"},{"key":"5262_CR50","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3171\/2016.3.JNS152836","volume":"126","author":"AG Wernicke","year":"2017","unstructured":"Wernicke AG, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S et al. (2017) Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg 126:1212\u20131219","journal-title":"J Neurosurg"},{"key":"5262_CR51","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3171\/2021.10.JNS211886","volume":"137","author":"WC Chen","year":"2022","unstructured":"Chen WC, Lafreniere M, Phuong C, Liu SJ, Baal JD, Lometti M et al. (2022) Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. J Neurosurg 137:924\u2013930","journal-title":"J Neurosurg"},{"key":"5262_CR52","doi-asserted-by":"crossref","unstructured":"Xia Y, Mashouf LA, Baker BR, Maxwell R, Bettegowda C, Redmond KJ et al. (2018) Outcomes of metastatic brain lesions treated with radioactive Cs-131 seeds after surgery: experience from one institution. Cureus","DOI":"10.7759\/cureus.3075"},{"key":"5262_CR53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3171\/2020.3.JNS193419","volume":"134","author":"DA Julie","year":"2021","unstructured":"Julie DA, Lazow SP, Vanderbilt DB, Taube S, Yondorf MZ, Sabbas A et al. (2021) A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases. J Neurosurg 134:1447\u20131454","journal-title":"J Neurosurg"},{"key":"5262_CR54","doi-asserted-by":"crossref","unstructured":"Nakaji P, Smith K, Youssef E, Thomas T, Pinnaduwage D, Rogers L et al. (2020) Resection and surgically targeted radiation therapy for the treatment of larger recurrent or newly diagnosed brain metastasis: results from a prospective trial. Cureus","DOI":"10.7759\/cureus.11570"},{"key":"5262_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-022-04101-9","volume":"159","author":"BS Imber","year":"2022","unstructured":"Imber BS, Young RJ, Beal K, Reiner AS, Giantini-Larsen AM, Krebs S et al. (2022) Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases. J Neurooncol 159:609\u2013618","journal-title":"J Neurooncol"},{"key":"5262_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11060-022-04050-3","volume":"159","author":"P Palmisciano","year":"2022","unstructured":"Palmisciano P, Haider AS, Balasubramanian K, D\u2019Amico RS, Wernicke AG (2022) The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials. J Neurooncol 159:117\u2013133","journal-title":"J Neurooncol"},{"issue":"1","key":"5262_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s44337-024-00169-6","volume":"2","author":"KW Sun","year":"2025","unstructured":"Sun KW, Zhu P, Do TH, Chen CC (2025) Impact of adjuvant interstitial brachytherapy on lengths of stay, discharge disposition, and 30-\/90-day readmission for malignant brain tumor patients: a national readmission database analysis. Discover Med 2(1):23","journal-title":"Discover Med"},{"key":"5262_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2377-10-109","volume":"10","author":"CC Chen","year":"2010","unstructured":"Chen CC, Zinn PO, Kasper EM, Ogilvy CS (2010) Cranio-spinal migration of a metallic clip placed during arteriovenous malformation resection - a case report, review of the literature, and management strategies. BMC Neurol 10:109","journal-title":"BMC Neurol"},{"key":"5262_CR59","doi-asserted-by":"crossref","unstructured":"Kotre CJ (2022) ALARP: when does reasonably practicable become rather pricey? The Br J Radiol 95:1138","DOI":"10.1259\/bjr.20220612"},{"key":"5262_CR60","doi-asserted-by":"crossref","unstructured":"Palavani LB, De Barros Oliveira L, Reis PA, Batista S, Santana LS, De Freitas Martins LP et al. (2024) Efficacy and safety of Intraoperative radiotherapy for high-grade gliomas: a systematic review and meta-analysis. Neurosurg Rev 47","DOI":"10.1007\/s10143-024-02279-2"},{"key":"5262_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3109\/02841867109130786","volume":"10","author":"M Abe","year":"1971","unstructured":"Abe M, Fukuda M, Yamano K, Matsuda S, Handa H (1971) Intra-operative irradiation in abdominal and cerebral tumours. Acta Radiol Ther Phys Biol 10:408\u2013416","journal-title":"Acta Radiol Ther Phys Biol"},{"key":"5262_CR62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/01616412.1995.11740329","volume":"17","author":"O de Urbina D","year":"1995","unstructured":"Ortiz de Urbina D, Santos M, Garcia-Berrocal I, Bustos JC, Samblas J, Gutierrez-Diaz JA et al. (1995) Intraoperative radiation therapy in malignant glioma: early clinical results. Neurol Res 17:289\u2013294","journal-title":"Neurol Res"},{"key":"5262_CR63","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0360-3016(81)90001-8","volume":"7","author":"M Abe","year":"1981","unstructured":"Abe M, Takahashi M (1981) Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 7:863\u2013868","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5262_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.brachy.2020.11.004","volume":"20","author":"BA Dahshan","year":"2021","unstructured":"Dahshan BA, Weir JS, Bice RP, Renz P, Cifarelli DT, Poplawski L et al. (2021) Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: comparison of IORT, SRS, and IMRT indices. Brachytherapy 20(2):426\u2013432","journal-title":"Brachytherapy"},{"key":"5262_CR65","doi-asserted-by":"crossref","unstructured":"Pascual JSG, Cruz-Lim EMD, Ylanan AMD, Ignacio KHD, Ca\u00f1al JPA, Khu KJO (2021) Treatment protocols and Oe Radioutcomes of intraoperativtherapy for brain metastases: a systematic review. EJMO 5","DOI":"10.14791\/btrt.2022.10.F-1303"},{"issue":"2","key":"5262_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1227\/NEU.0b013e31827b99f3","volume":"72","author":"B Atalar","year":"2013","unstructured":"Atalar B, Choi CYH, Harsh GRI, Chang SD, Gibbs IC, Adler JR et al. (2013) Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery 72(2):180\u2013185","journal-title":"Neurosurgery"},{"key":"5262_CR67","unstructured":"Intracavitary Carrier-embedded Cs131 brachytherapy for recurrent brain metastases: a randomized phase II study (ed) Gt medical technologies I (2020)"},{"key":"5262_CR68","unstructured":"A phase 3 randomized controlled trial of post-surgical stereotactic radiotherapy (SRT) versus surgically targeted radiation therapy (STaRT) with gamma tile for treatment of newly diagnosed metastatic brain tumors (2020)"},{"key":"5262_CR69","unstructured":"A multicenter observational study of GammaTile\u2122 surgically targeted radiation therapy (STaRT) in intracranial brain neoplasms (2020)"},{"key":"5262_CR70","unstructured":"Pilot study of resection and GammaTile followed by concomitant external beam radiation therapy (EBRT) and Temozolomide (TMZ) and adjuvant in newly diagnosed glioblastoma (GBM) (2022)"},{"key":"5262_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jocn.2023.01.010","volume":"109","author":"P Palmisciano","year":"2023","unstructured":"Palmisciano P, Haider AS, Balasubramanian K, Boockvar JA, Schwartz TH, D\u2019Amico RS et al. (2023) Cesium-131 brachytherapy for the treatment of brain metastases: current status and future perspectives. J Clin Neurosci 109:57\u201363","journal-title":"J Clin Neurosci"},{"key":"5262_CR72","doi-asserted-by":"crossref","unstructured":"Liu S, Wang W, Hu S, Jia B, Tuo B, Sun H et al. (2023) Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. Cell Death Dis 14","DOI":"10.1038\/s41419-023-06211-2"}],"updated-by":[{"DOI":"10.1007\/s11060-026-05593-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05262-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:05:48Z","timestamp":1778331948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05262-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5262"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05262-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11060-026-05593-5","URL":"https:\/\/doi.org\/10.1007\/s11060-026-05593-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CPC received speaking honoraria from Carl Zeiss Meditec, AG. CCC and BD served as consultants for and received speaking honoraria from GT Medical Technology, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}